Skinosive Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.08M
- Investors
-
3
Skinosive General Information
Description
Developer of a science-driven dermo-cosmetics biotechnology company designed for skin photoprotection. The company offers bio-adhesion technology that filters and provides extended sun protection while being well-tolerated and eco-friendly, enabling lasting sun protection and preventing Ultraviolet (UV) filters from being absorbed through the skin and the bloodstream.
Contact Information
Website
www.skinosive.comCorporate Office
- 12-14 Rue Jean-Antoine De Baif
- 75013 Paris
- France
Corporate Office
- 12-14 Rue Jean-Antoine De Baif
- 75013 Paris
- France
Skinosive Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 04-Mar-2024 | $1.08M | Completed | Clinical Trials - General | ||
| 3. Early Stage VC | 09-Oct-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup |
Skinosive Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| P Shares | ||||||||
| P Shares | ||||||||
| P Shares | 500,000 | $1.079524 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Skinosive Patents
Skinosive Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026146043-A1 | Adhesive photoprotective compounds and uses thereof | Pending | 30-Dec-2024 | ||
| WO-2025229086-A1 | Adhesive cosmetic compounds and uses thereof | Pending | 30-Apr-2024 | ||
| AU-2024305004-A1 | Adhesive photoprotective compounds and uses thereof | Pending | 14-Jun-2023 | ||
| EP-4727919-A1 | Adhesive photoprotective compounds and uses thereof | Pending | 14-Jun-2023 | ||
| WO-2024256597-A1 | Adhesive photoprotective compounds and uses thereof | Inactive | 14-Jun-2023 | C07D207/452 |
Skinosive Signals
Skinosive Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Truffle Capital | Venture Capital | Minority | ||
| OBRATORI | Corporate Venture Capital | Minority | ||
| La French Tech Aix-Marseille Région Sud | Accelerator/Incubator |
Skinosive FAQs
-
When was Skinosive founded?
Skinosive was founded in 2017.
-
Where is Skinosive headquartered?
Skinosive is headquartered in Paris, France.
-
What is the size of Skinosive?
Skinosive has 10 total employees.
-
What industry is Skinosive in?
Skinosive’s primary industry is Personal Products.
-
Is Skinosive a private or public company?
Skinosive is a Private company.
-
What is the current valuation of Skinosive?
The current valuation of Skinosive is .
-
What is Skinosive’s current revenue?
The current revenue for Skinosive is .
-
How much funding has Skinosive raised over time?
Skinosive has raised $3.41M.
-
Who are Skinosive’s investors?
Truffle Capital, OBRATORI, and La French Tech Aix-Marseille Région Sud have invested in Skinosive.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process